LOGIN
Sequential Intravenous Tranexamic Acid After Posterior Lumbar Interbody Fusion
January 2024
Sequential Intravenous Tranexamic Acid After Posterior Lumbar Interbody Fusion
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
The effect of sequential perioperative intravenous tranexamic acid in reducing postoperative blood loss and hidden blood loss after posterior lumbar interbody fusion: a randomized controlled trial.
Front Med (Lausanne) . 2023 Aug 4:10:1192971.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
123 patients undergoing posterior lumbar interbody fusion (PLIF) were randomized to receive either sequential perioperative intravenous tranexamic acid (TXA; n=63) or a saline control (n=59). The primary outcomes of interest included hidden blood loss (HBL) and postoperative blood loss (PBL). Secondary outcomes of interest included total blood loss (TBL), drainage removal time (DRT), length of sta...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.